For the first time, Uber Health users, including healthcare providers and health plans, will be able to manage prescription delivery from any pharmacy in their service area via the same platform they use to coordinate patient transportation. This launch allows providers to offer a comprehensive suite of care solutions that extend beyond the four walls of a clinic and is intended to improve patient experiences and health outcomes.

This activity aims to educate the multidisciplinary care team treating pediatric ADHD, including psychiatrists, pediatricians, PCPs, pharmacists, and dietitians/nutritionists. After completion, participants will be better able to describe the role of dietary deficiencies of essential fatty acids (EFAs) and genetic variants of metabolism in the pathophysiology of ADHD; review the most recent data on the safety and efficacy of supplementation with EFAs for ADHD management in children and adolescents; differentiate dietary supplements from medical foods; and create personalized nutritional therapy plans for ADHD patients by considering the individual needs of each patient and the differences among available dietary products.

According to the FDA, more than 101,000 fatal overdoses were reported during the 12-month period that ended in October 2022. Nearly half of fatal overdoses involve bystanders, but naloxone is only used in a small percentage of those situations. According to medical professionals who support the approval, there would be a critical opportunity to close this gap and lower the number of opioid-related deaths if naloxone were available over-the-counter.

The DEA has issued a warning after discovering xylazine, a tranquilizer for large animals, in almost 25% of the fentanyl powder it seized in 2022. Extensive, necrotic skin ulcerations brought on by xylazine can even result in amputation due to the drug’s ability to impair breathing and cause overdoses. The Combating Illicit Xylazine Act would reclassify the drug as a Schedule III drug, designate it as an emerging threat, and give the DEA the ability to monitor the drug’s production.

When a pharmacy experiences a data breach, the incident may be expensive to fix, interfere with patient care, and lead to legal action. Pharmacies are a “treasure trove” of information for criminals because they hold financial and healthcare information, making them the golden goose for criminals. Everyone is a target, from big chains to tiny independent pharmacies. Experts offer guidance on how to maintain vigilance.

Anyone who handles controlled substances must review their policies and procedures for identifying suspect prescriptions and taking appropriate action when necessary. Safe controlled substance (CS) handling procedures must also be followed by manufacturers and distributors. Thankfully, pharmacies can use tactics to spot questionable prescriptions, evade DEA inspections, and—most importantly—protect the health of their customers. But what comes first? Understanding what a red-flag prescription is.